Genomics of Lipid Metabolism: Identifying Novel Causal Pathways and New Therapeutic Targets for Reducing risk of Coronary Heart Disease

被引：0
|
作者：
Harshfield, Eric L. [1 ]
Stacey, David [1 ]
Paul, Dirk S. [1 ]
Koulman, Albert [2 ]
Wood, Angela M. [1 ]
Butterworth, Adam S. [1 ]
Fauman, Eric [3 ]
Griffin, Julian L. [2 ]
Danesh, John [1 ]
Saleheen, Danish [4 ]
机构：
[1] Univ Cambridge, Sch Clin Med, Dept Publ Hlth & Primary Care, Cambridge, England
[2] Univ Cambridge, MRC Human Nutr Res, Cambridge, England
[3] Pfizer Worldwide Res & Dev, Computat Sci Ctr Emphasis, Cambridge, MA USA
[4] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
来源：
GENETIC EPIDEMIOLOGY | 2016年 / 40卷 / 07期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
17
引用
收藏
页码：614 / 615
页数：2
相关论文
共 29 条
  • [1] Microparticles as Novel Biomarkers and Therapeutic Targets in Coronary Heart Disease
    Zhou Bo-Da
    Guo Ge
    Zheng Le-Min
    Zu Ling-Yun
    Gao Wei
    [J]. 中华医学杂志(英文版), 2015, 128 (02) : 267 - 272
  • [2] Microparticles as Novel Biomarkers and Therapeutic Targets in Coronary Heart Disease
    Zhou, Bo-Da
    Guo, Ge
    Zheng, Le-Min
    Zu, Ling-Yun
    Gao, Wei
    [J]. CHINESE MEDICAL JOURNAL, 2015, 128 (02) : 267 - 272
  • [3] New Molecular Mechanisms for Cardiovascular Disease: Transcriptional Pathways and Novel Therapeutic Targets in Heart Failure
    Kuwahara, Koichiro
    Nakao, Kazuwa
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 116 (04) : 337 - 342
  • [4] Role of Coronary Vasoconstriction in Ischemic Heart Disease and Search for Novel Therapeutic Targets
    Maseri, Attillio
    Beltrame, John F.
    Shimokawa, Hiroaki
    [J]. CIRCULATION JOURNAL, 2009, 73 (03) : 394 - 403
  • [5] Gene: environment interaction in lipid metabolism and effect on coronary heart disease risk
    Talmud, PJ
    Humphries, SE
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (02) : 149 - 154
  • [6] New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimer's disease
    Cao, Yuan
    Zhao, Lin-Wei
    Chen, Zi-Xin
    Li, Shao-Hua
    [J]. FRONTIERS IN NEUROSCIENCE, 2024, 18
  • [7] Genetics of coronary heart disease: towards causal mechanisms, novel drug targets and more personalized prevention
    Orho-Melander, M.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2015, 278 (05) : 433 - 446
  • [8] Glycoregulation and lipid metabolism disorders in diabetes mellitus: cumulative risk for coronary heart disease
    Zivkovic, M.
    Icic, M.
    [J]. SWISS MEDICAL WEEKLY, 2009, 139 (33-34) : 162S - 162S
  • [9] Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
    María Gordillo-Marañón
    Magdalena Zwierzyna
    Pimphen Charoen
    Fotios Drenos
    Sandesh Chopade
    Tina Shah
    Jorgen Engmann
    Nishi Chaturvedi
    Olia Papacosta
    Goya Wannamethee
    Andrew Wong
    Reecha Sofat
    Mika Kivimaki
    Jackie F. Price
    Alun D. Hughes
    Tom R. Gaunt
    Deborah A. Lawlor
    Anna Gaulton
    Aroon D. Hingorani
    Amand F. Schmidt
    Chris Finan
    [J]. Nature Communications, 12
  • [10] Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
    Gordillo-Maranon, Maria
    Zwierzyna, Magdalena
    Charoen, Pimphen
    Drenos, Fotios
    Chopade, Sandesh
    Shah, Tina
    Engmann, Jorgen
    Chaturvedi, Nishi
    Papacosta, Olia
    Wannamethee, Goya
    Wong, Andrew
    Sofat, Reecha
    Kivimaki, Mika
    Price, Jackie F.
    Hughes, Alun D.
    Gaunt, Tom R.
    Lawlor, Deborah A.
    Gaulton, Anna
    Hingorani, Aroon D.
    Schmidt, Amand F.
    Finan, Chris
    [J]. NATURE COMMUNICATIONS, 2021, 12 (01)
123